Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation

Laryngeal squamous cell carcinoma (LSCC) is a common head and neck cancer. Despite recently improved management of LSCC, chemotherapy resistance of patients remains a challenge. In this study, we identified that long noncoding RNA FOXD2-AS1 regulates LSCC therapeutic resistance by augmenting LSCC st...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Chen, Shuwei, Zhan, Jiandong, Li, Xinghua, Liu, Wenlin, Sheng, Xiaoli, Lu, Zhongming, Zhong, Rong, Chen, Liangsi, Luo, Xiaoning, Hu, Yameng, Ouyang, Ying, Liu, Tao, Zhang, Quan, Zhang, Siyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971019/
https://www.ncbi.nlm.nih.gov/pubmed/31959918
http://dx.doi.org/10.1038/s41419-020-2232-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971019/
https://www.ncbi.nlm.nih.gov/pubmed/31959918
http://dx.doi.org/10.1038/s41419-020-2232-7

Ejemplares similares